For research use only. Not for therapeutic Use.
21-Desacetyldeflazacort-d5, a premium pharmaceutical research compound designed for advanced anti-inflammatory and immunosuppressive studies. As a deuterated analog of 21-Desacetyldeflazacort, it offers enhanced stability and improved pharmacokinetic properties. 21-Desacetyldeflazacort-d5 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for inflammatory and autoimmune disorders. Trusted by leading laboratories, 21-Desacetyldeflazacort-d5 is your go-to solution for cutting-edge research in inflammation and immunosuppression. Unlock new possibilities in treatment with 21-Desacetyldeflazacort-d5, where innovation meets reliability.
| Catalog Number | S000218 |
| Molecular Formula | C23H24D5NO5 |
| Purity | ≥95% |
| Target | Vitamin D Related/Nuclear Receptor |
| IUPAC Name | (1S,2S,4R,8S,9S,11S,12S,13R)-8-(2,2-dideuterio-2-hydroxyacetyl)-11-hydroxy-9,13-dimethyl-6-(trideuteriomethyl)-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-16-one |
| InChI | InChI=1S/C23H29NO5/c1-12-24-23(18(28)11-25)19(29-12)9-16-15-5-4-13-8-14(26)6-7-21(13,2)20(15)17(27)10-22(16,23)3/h6-8,15-17,19-20,25,27H,4-5,9-11H2,1-3H3/t15-,16-,17-,19+,20+,21-,22-,23+/m0/s1/i1D3,11D2 |
| InChIKey | KENSGCYKTRNIST-WDVKEZEISA-N |
| SMILES | [2H]C([2H])([2H])C1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)C([2H])([2H])O |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
